ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Flu Prevention Market Research Report 2026
Published Date: 2026-02-04
|
Report Code: QYRE-Auto-2T18685
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Flu Prevention Market Research Report 2024
BUY CHAPTERS

Global Flu Prevention Market Research Report 2026

Code: QYRE-Auto-2T18685
Report
2026-02-04
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Viatris
Astrazeneca plc
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics

Flu Prevention Market Size

The global Flu Prevention market was valued at US$ 9402 million in 2025 and is anticipated to reach US$ 13640 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Flu Prevention Market

Flu Prevention Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Flu Prevention competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Flu prevention encompasses a range of measures aimed at reducing the risk of influenza infection. Key methods include annual vaccination, which is the most effective way to prevent flu, along with practices such as frequent handwashing, avoiding close contact with infected individuals, and maintaining good hygiene. For those at high risk, like young children, elderly adults, and individuals with chronic health conditions, flu prevention is crucial to reduce the chance of severe illness and complications.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
This report delivers a comprehensive overview of the global Flu Prevention market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Flu Prevention. The Flu Prevention market size, estimates, and forecasts are provided in terms of sales volume (M Doses) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Flu Prevention market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Flu Prevention manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Flu Prevention Market Report

Report Metric Details
Report Name Flu Prevention Market
Accounted market size in 2025 US$ 9402 million
Forecasted market size in 2032 US$ 13640 million
CAGR 5.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
by Application
  • 6 Months to 3 Years
  • > 3 Years
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Flu Prevention manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Flu Prevention sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Flu Prevention Market growing?

Ans: The Flu Prevention Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the Flu Prevention Market size in 2032?

Ans: The Flu Prevention Market size in 2032 will be US$ 13640 million.

What is the market share of major companies in Flu Prevention Market?

Ans: The top five players hold a share about 75%.

What is the Flu Prevention Market share by region?

Ans: North America is the largest market, has a share about 50%.

Who are the main players in the Flu Prevention Market report?

Ans: The main players in the Flu Prevention Market are Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics

What are the Application segmentation covered in the Flu Prevention Market report?

Ans: The Applications covered in the Flu Prevention Market report are 6 Months to 3 Years, > 3 Years

What are the Type segmentation covered in the Flu Prevention Market report?

Ans: The Types covered in the Flu Prevention Market report are Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine

1 Flu Prevention Market Overview
1.1 Product Definition
1.2 Flu Prevention by Type
1.2.1 Global Flu Prevention Market Value by Type: 2025 vs 2032
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Prevention by Application
1.3.1 Global Flu Prevention Market Value by Application: 2025 vs 2032
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Flu Prevention Market Size Estimates and Forecasts
1.4.1 Global Flu Prevention Revenue 2021–2032
1.4.2 Global Flu Prevention Sales 2021–2032
1.4.3 Global Flu Prevention Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Flu Prevention Market Competition by Manufacturers
2.1 Global Flu Prevention Sales Market Share by Manufacturers (2021–2026)
2.2 Global Flu Prevention Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Flu Prevention Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Flu Prevention, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Flu Prevention, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Flu Prevention, Product Types and Applications
2.7 Global Key Manufacturers of Flu Prevention, Date of Entry into the Industry
2.8 Global Flu Prevention Market Competitive Situation and Trends
2.8.1 Global Flu Prevention Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Flu Prevention Players Market Share by Revenue
2.8.3 Global Flu Prevention Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Flu Prevention Market Scenario by Region
3.1 Global Flu Prevention Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Flu Prevention Sales by Region: 2021–2032
3.2.1 Global Flu Prevention Sales by Region: 2021–2026
3.2.2 Global Flu Prevention Sales by Region: 2027–2032
3.3 Global Flu Prevention Revenue by Region: 2021–2032
3.3.1 Global Flu Prevention Revenue by Region: 2021–2026
3.3.2 Global Flu Prevention Revenue by Region: 2027–2032
3.4 North America Flu Prevention Market Facts & Figures by Country
3.4.1 North America Flu Prevention Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Flu Prevention Sales by Country (2021–2032)
3.4.3 North America Flu Prevention Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Flu Prevention Market Facts & Figures by Country
3.5.1 Europe Flu Prevention Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Flu Prevention Sales by Country (2021–2032)
3.5.3 Europe Flu Prevention Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flu Prevention Market Facts & Figures by Region
3.6.1 Asia Pacific Flu Prevention Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Flu Prevention Sales by Region (2021–2032)
3.6.3 Asia Pacific Flu Prevention Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Flu Prevention Market Facts & Figures by Country
3.7.1 Latin America Flu Prevention Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Flu Prevention Sales by Country (2021–2032)
3.7.3 Latin America Flu Prevention Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flu Prevention Market Facts & Figures by Country
3.8.1 Middle East and Africa Flu Prevention Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Flu Prevention Sales by Country (2021–2032)
3.8.3 Middle East and Africa Flu Prevention Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Flu Prevention Sales by Type (2021–2032)
4.1.1 Global Flu Prevention Sales by Type (2021–2026)
4.1.2 Global Flu Prevention Sales by Type (2027–2032)
4.1.3 Global Flu Prevention Sales Market Share by Type (2021–2032)
4.2 Global Flu Prevention Revenue by Type (2021–2032)
4.2.1 Global Flu Prevention Revenue by Type (2021–2026)
4.2.2 Global Flu Prevention Revenue by Type (2027–2032)
4.2.3 Global Flu Prevention Revenue Market Share by Type (2021–2032)
4.3 Global Flu Prevention Price by Type (2021–2032)
5 Segment by Application
5.1 Global Flu Prevention Sales by Application (2021–2032)
5.1.1 Global Flu Prevention Sales by Application (2021–2026)
5.1.2 Global Flu Prevention Sales by Application (2027–2032)
5.1.3 Global Flu Prevention Sales Market Share by Application (2021–2032)
5.2 Global Flu Prevention Revenue by Application (2021–2032)
5.2.1 Global Flu Prevention Revenue by Application (2021–2026)
5.2.2 Global Flu Prevention Revenue by Application (2027–2032)
5.2.3 Global Flu Prevention Revenue Market Share by Application (2021–2032)
5.3 Global Flu Prevention Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Sanofi Flu Prevention Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Company Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CSL Flu Prevention Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 GSK Flu Prevention Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Company Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Viatris Flu Prevention Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 AstraZeneca Flu Prevention Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Company Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hualan Bio Flu Prevention Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.7.1 Changchun Institute of Biological Company Information
6.7.2 Changchun Institute of Biological Description and Business Overview
6.7.3 Changchun Institute of Biological Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Changchun Institute of Biological Flu Prevention Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Company Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sinovac Flu Prevention Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Company Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 BCHT Flu Prevention Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Company Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Jiangsu GDK Flu Prevention Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Company Information
6.11.2 KM Biologics Description and Business Overview
6.11.3 KM Biologics Flu Prevention Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 KM Biologics Flu Prevention Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flu Prevention Industry Chain Analysis
7.2 Flu Prevention Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flu Prevention Production Mode & Process Analysis
7.4 Flu Prevention Sales and Marketing
7.4.1 Flu Prevention Sales Channels
7.4.2 Flu Prevention Distributors
7.5 Flu Prevention Customer Analysis
8 Flu Prevention Market Dynamics
8.1 Flu Prevention Industry Trends
8.2 Flu Prevention Market Drivers
8.3 Flu Prevention Market Challenges
8.4 Flu Prevention Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Viatris
Astrazeneca plc
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
List of Tables
 Table 1. Global Flu Prevention Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Flu Prevention Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Flu Prevention Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Flu Prevention Sales (M Doses) of Key Manufacturers (2021–2026)
 Table 5. Global Flu Prevention Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Flu Prevention Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Flu Prevention Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Flu Prevention Average Price (USD/Doses) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Flu Prevention, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Flu Prevention, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Flu Prevention, Product Types and Applications
 Table 12. Global Key Manufacturers of Flu Prevention, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Flu Prevention Companies by Tier (Tier 1, Tier 2, Tier 3), based on Flu Prevention Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Flu Prevention Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Flu Prevention Sales by Region (M Doses), 2021–2026
 Table 18. Global Flu Prevention Sales Market Share by Region (2021–2026)
 Table 19. Global Flu Prevention Sales by Region (M Doses), 2027–2032
 Table 20. Global Flu Prevention Sales Market Share by Region (2027–2032)
 Table 21. Global Flu Prevention Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Flu Prevention Revenue Market Share by Region (2021–2026)
 Table 23. Global Flu Prevention Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Flu Prevention Revenue Market Share by Region (2027–2032)
 Table 25. North America Flu Prevention Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Flu Prevention Sales by Country (M Doses), 2021–2026
 Table 27. North America Flu Prevention Sales by Country (M Doses), 2027–2032
 Table 28. North America Flu Prevention Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Flu Prevention Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Flu Prevention Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Flu Prevention Sales by Country (M Doses), 2021–2026
 Table 32. Europe Flu Prevention Sales by Country (M Doses), 2027–2032
 Table 33. Europe Flu Prevention Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Flu Prevention Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Flu Prevention Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Flu Prevention Sales by Region (M Doses), 2021–2026
 Table 37. Asia Pacific Flu Prevention Sales by Region (M Doses), 2027–2032
 Table 38. Asia Pacific Flu Prevention Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Flu Prevention Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Flu Prevention Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Flu Prevention Sales by Country (M Doses), 2021–2026
 Table 42. Latin America Flu Prevention Sales by Country (M Doses), 2027–2032
 Table 43. Latin America Flu Prevention Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Flu Prevention Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Flu Prevention Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Flu Prevention Sales by Country (M Doses), 2021–2026
 Table 47. Middle East and Africa Flu Prevention Sales by Country (M Doses), 2027–2032
 Table 48. Middle East and Africa Flu Prevention Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Flu Prevention Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Flu Prevention Sales (M Doses) by Type (2021–2026)
 Table 51. Global Flu Prevention Sales (M Doses) by Type (2027–2032)
 Table 52. Global Flu Prevention Sales Market Share by Type (2021–2026)
 Table 53. Global Flu Prevention Sales Market Share by Type (2027–2032)
 Table 54. Global Flu Prevention Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Flu Prevention Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Flu Prevention Revenue Market Share by Type (2021–2026)
 Table 57. Global Flu Prevention Revenue Market Share by Type (2027–2032)
 Table 58. Global Flu Prevention Price (USD/Doses) by Type (2021–2026)
 Table 59. Global Flu Prevention Price (USD/Doses) by Type (2027–2032)
 Table 60. Global Flu Prevention Sales (M Doses) by Application (2021–2026)
 Table 61. Global Flu Prevention Sales (M Doses) by Application (2027–2032)
 Table 62. Global Flu Prevention Sales Market Share by Application (2021–2026)
 Table 63. Global Flu Prevention Sales Market Share by Application (2027–2032)
 Table 64. Global Flu Prevention Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Flu Prevention Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Flu Prevention Revenue Market Share by Application (2021–2026)
 Table 67. Global Flu Prevention Revenue Market Share by Application (2027–2032)
 Table 68. Global Flu Prevention Price (USD/Doses) by Application (2021–2026)
 Table 69. Global Flu Prevention Price (USD/Doses) by Application (2027–2032)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 73. Sanofi Flu Prevention Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. CSL Company Information
 Table 76. CSL Description and Business Overview
 Table 77. CSL Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 78. CSL Flu Prevention Product
 Table 79. CSL Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 83. GSK Flu Prevention Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Viatris Company Information
 Table 86. Viatris Description and Business Overview
 Table 87. Viatris Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 88. Viatris Flu Prevention Product
 Table 89. Viatris Recent Developments/Updates
 Table 90. AstraZeneca Company Information
 Table 91. AstraZeneca Description and Business Overview
 Table 92. AstraZeneca Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 93. AstraZeneca Flu Prevention Product
 Table 94. AstraZeneca Recent Developments/Updates
 Table 95. Hualan Bio Company Information
 Table 96. Hualan Bio Description and Business Overview
 Table 97. Hualan Bio Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 98. Hualan Bio Flu Prevention Product
 Table 99. Hualan Bio Recent Developments/Updates
 Table 100. Changchun Institute of Biological Company Information
 Table 101. Changchun Institute of Biological Description and Business Overview
 Table 102. Changchun Institute of Biological Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 103. Changchun Institute of Biological Flu Prevention Product
 Table 104. Changchun Institute of Biological Recent Developments/Updates
 Table 105. Sinovac Company Information
 Table 106. Sinovac Description and Business Overview
 Table 107. Sinovac Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 108. Sinovac Flu Prevention Product
 Table 109. Sinovac Recent Developments/Updates
 Table 110. BCHT Company Information
 Table 111. BCHT Description and Business Overview
 Table 112. BCHT Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 113. BCHT Flu Prevention Product
 Table 114. BCHT Recent Developments/Updates
 Table 115. Jiangsu GDK Company Information
 Table 116. Jiangsu GDK Description and Business Overview
 Table 117. Jiangsu GDK Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 118. Jiangsu GDK Flu Prevention Product
 Table 119. Jiangsu GDK Recent Developments/Updates
 Table 120. KM Biologics Company Information
 Table 121. KM Biologics Description and Business Overview
 Table 122. KM Biologics Flu Prevention Sales (M Doses), Revenue (US$ Million), Price (USD/Doses), and Gross Margin (2021–2026)
 Table 123. KM Biologics Flu Prevention Product
 Table 124. KM Biologics Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Flu Prevention Distributors List
 Table 128. Flu Prevention Customers List
 Table 129. Flu Prevention Market Trends
 Table 130. Flu Prevention Market Drivers
 Table 131. Flu Prevention Market Challenges
 Table 132. Flu Prevention Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Flu Prevention
 Figure 2. Global Flu Prevention Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Flu Prevention Market Share by Type: 2025 & 2032
 Figure 4. Trivalent Influenza Vaccine Product Picture
 Figure 5. Quadrivalent Influenza Vaccine Product Picture
 Figure 6. Global Flu Prevention Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Flu Prevention Market Share by Application: 2025 & 2032
 Figure 8. 6 Months to 3 Years
 Figure 9. > 3 Years
 Figure 10. Global Flu Prevention Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 11. Global Flu Prevention Market Size (US$ Million), 2021–2032
 Figure 12. Global Flu Prevention Sales (M Doses), 2021–2032
 Figure 13. Global Flu Prevention Average Price (USD/Doses), 2021–2032
 Figure 14. Flu Prevention Report Years Considered
 Figure 15. Flu Prevention Sales Share by Manufacturers in 2025
 Figure 16. Global Flu Prevention Revenue Share by Manufacturers in 2025
 Figure 17. Top 5 and Top 10 Global Flu Prevention Players: Market Share by Revenue in Flu Prevention in 2025
 Figure 18. Flu Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 19. Global Flu Prevention Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 20. North America Flu Prevention Sales Market Share by Country (2021–2032)
 Figure 21. North America Flu Prevention Revenue Market Share by Country (2021–2032)
 Figure 22. U.S. Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 23. Canada Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Europe Flu Prevention Sales Market Share by Country (2021–2032)
 Figure 25. Europe Flu Prevention Revenue Market Share by Country (2021–2032)
 Figure 26. Germany Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. France Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. U.K. Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Italy Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Russia Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Asia Pacific Flu Prevention Sales Market Share by Region (2021–2032)
 Figure 32. Asia Pacific Flu Prevention Revenue Market Share by Region (2021–2032)
 Figure 33. China Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Japan Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. South Korea Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. India Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Australia Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. China Taiwan Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Indonesia Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Thailand Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Malaysia Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Flu Prevention Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Flu Prevention Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Flu Prevention Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Flu Prevention Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Flu Prevention Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Flu Prevention by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Flu Prevention by Type (2021–2032)
 Figure 54. Global Flu Prevention Price (USD/Doses) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Flu Prevention by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Flu Prevention by Application (2021–2032)
 Figure 57. Global Flu Prevention Price (USD/Doses) by Application (2021–2032)
 Figure 58. Flu Prevention Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Paediatric Influenza Prevention Market Research Report 2024
Global Flu Vaccination Market Research Report 2025
Global Flu Vaccine Market Insights Forecast to 2030
Global Human Injection Flu Vaccine Market Research Report 2025
Global Injection Influenza Vaccine Market Research Report 2025
Global Flu RNA Vaccines Market Research Report 2025
Global Injection Flu Shot Market Research Report 2025
Global Influenza Subunit Vaccine Market Research Report 2024
Children Influenza Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti Influenza Virus Chinese Medicine Market Research Report 2024
Flu Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti H1N1 Liquid Mask Market Research Report 2025
Global Egg Based Flu Vaccines Market Research Report 2024
Influenza Virus Vaccine H1N1 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Adult Preventable Vaccines Market Research Report 2024
Global Egg free Flu Vaccine Market Research Report 2024
Global Poultry Vaccines Market Research Report 2025
Global Paediatric Influenza Treatment Market Research Report 2024
Global Adjuvanted Influenza Vaccine Market Research Report 2024
Global Pediatric Influenza Treatment Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions